Despite major interest in this pathway for cancer drug discovery, no drugs have yet been approved that act specifically against PI3K or its downstream regulator, AKT. However, several drugs that ...

When Akt is activated in otherwise normal cells, these cells become tumorigenic when they are mixed with other tumorigenic cells to form a tumour microenvironment. Lim et al. exploited this, and ...